XIORF(XIORF)
XIORF
$29.04—Stale · unknown old
OTC • Last print unknown ago
$29.04—Stale · unknown old
No analyst ratings available
No analyst price targets available for XIORF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $227M | $242M | $252M | $265M |
| Low | $221M | $231M | $243M | $256M |
| High | $231M | $248M | $258M | $271M |
| EBITDA Avg | $227M | $234M | $250M | $243M |
| Low | $219M | $226M | $241M | $235M |
| High | $233M | $240M | $256M | $249M |
| EBIT Avg | $226M | $233M | $248M | $241M |
| Low | $218M | $225M | $239M | $233M |
| High | $232M | $239M | $255M | $247M |
| Net Income Avg | $146M | $151M | $164M | $158M |
| Low | $139M | $145M | $157M | $151M |
| High | $151M | $156M | $169M | $163M |
| EPS Avg | $2.67 | $2.76 | $3.00 | $2.89 |
| Low | $2.55 | $2.64 | $2.86 | $2.76 |
| High | $2.75 | $2.85 | $3.09 | $2.98 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 5 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q3 2028 |
|---|---|---|---|
| Revenue Avg | $63M | $23M | $56M |
| Low | $63M | $23M | $56M |
| High | $63M | $23M | $56M |
| EBITDA Avg | — | — | $51M |
| Low | — | — | $51M |
| High | — | — | $51M |
| EBIT Avg | — | — | $51M |
| Low | — | — | $51M |
| High | — | — | $51M |
| Net Income Avg | $75M | $37M | $35M |
| Low | $75M | $37M | $35M |
| High | $75M | $37M | $35M |
| EPS Avg | $1.41 | $0.69 | $0.66 |
| Low | $1.41 | $0.69 | $0.66 |
| High | $1.41 | $0.69 | $0.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |